MedPage Today on MSN

Incretin therapies after bariatric surgery linked to lower risk of alcohol disorder

Treatment with incretin-based weight-loss medications, like GLP-1 receptor agonists, after bariatric surgery was associated with significantly lower risks of alcohol use disorder (AUD) and initiation ...
MedPage Today on MSN

Liver disease medication linked to lower cancer risks

Treatment with ursodeoxycholic acid (UDCA) in adults with primary biliary cholangitis (PBC) was associated with significantly lower risks of certain cancers, a retrospective propensity-score matched ...
Medical Dialogues

UDCA Use in Primary Biliary Cholangitis Associated With Reduced Cancer Risk: JAMA

USA: A large retrospective, propensity score–matched cohort study found that ursodeoxycholic acid (UDCA) use in patients with ...
ascopubs.org

Propensity score (PS) comparison between lisocabtagene maraleucel (liso-cel) plus ibrutinib combination therapy (combo) and liso-cel monotherapy (mono) cohorts from TRANSCEND CLL.

Final analysis of fixed-duration ibrutinib + venetoclax for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in the phase 2 CAPTIVATE study. Preliminary safety and efficacy data of ...
Medscape

Domperidone Safety for Postpartum Mental Health: Findings Challenge Recent Regulatory Warnings

Postpartum use of domperidone to increase milk production in breastfeeding is not correlated with increased mental health-related emergency department visits.

Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet ...

Detailed price information for Stoke Therapeutics Inc (STOK-Q) from The Globe and Mail including charting and trades.